DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceBusiness Wire • 01/11/21
DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD StudyBusiness Wire • 12/15/20
DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic StrokeBusiness Wire • 12/10/20
DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/19/20
DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select ConferenceBusiness Wire • 11/11/20
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
DiaMedica Provides a Business Update and Third Quarter 2020 Financial ResultsBusiness Wire • 11/04/20
DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020Business Wire • 10/28/20
DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020Business Wire • 09/15/20
DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical StudyBusiness Wire • 09/14/20
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
DiaMedica Provides a Business Update and Second Quarter 2020 Financial ResultsBusiness Wire • 08/11/20
DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020Business Wire • 08/06/20
DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/24/20
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19
DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019GlobeNewsWire • 09/06/19
DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor ConferenceGlobeNewsWire • 09/03/19
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/14/19
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/14/19